Inhibitory effects of ginkgolides on nitric oxide production in neonatal rat microglia in vitro

Acta Pharmacologica Sinica

Volumn 19, Issue 5, 1998, Pages 467-470

  Du, Ze Ying ^a   Li, Xiao Yu ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Apafant; Cultured cells; Ginkgolides; Lipopolysaccharides; Microglia; Nitric oxide; Nitroarginine; Platelet activating factor

Indexed keywords

APAFANT; GINKGOLIDE A; GINKGOLIDE B; LIPOPOLYSACCHARIDE; N(G) NITROARGININE; NITRIC OXIDE;

ANIMAL CELL; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; MICROGLIA; NERVE CELL LESION; NEUROTOXICITY; NEWBORN; NONHUMAN; RAT;

ANIMALS; ANIMALS, NEWBORN; AZEPINES; CELLS, CULTURED; DITERPENES; GINKGOLIDES; LACTONES; LIPOPOLYSACCHARIDES; MICROGLIA; NITRIC OXIDE; NITROARGININE; PLATELET AGGREGATION INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; TRIAZOLES;

EID: 0031687753     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Brosnan CF, Battistini L, Raine CS, Dickson DW, Casadevall A, Lee SC. Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci 1994; 16: 152 - 61.
2. Meda L, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, Villalba M, et al. Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 1995; 374: 647 - 50.
3. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. Activated microglia mediated neuronal cell injury via a nitric oxide mechanism. J Immunol 1992; 149: 2736 - 41.
4. Boje KM, Arora PK. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 1992; 587: 250 - 6.
5. Prehn JHM, Krieglstein J. Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo. J Neurosci Res 1993; 34: 179 - 88.
6. Faden AI, Tzendzalian PA. Platelet-activating factor antagonists limit glycine changes and behavioral deficits after brain trauma. Am J Physiol 1992; 263: R909 - 14.
7. 3H] D-aspartate release after ischaemia in vitro. Neuroreport 1994; 6: 85 - 8.
8. Keller M, Jackisch R, Seregi A, Hertting G. Comparison of prostanoid forming capacity of neuronal and astroglial cells in primary cultures. Neurochem Int 1985; 7: 655 - 65.
9. Appel K, Honegger P, Gebicke-Haerter PJ. Expression of interleukin-3 and tumor necrosis factor-β mRNAs in cultured microglia. J Neuroimmunol 1995; 60: 83 - 91.
10. Haves GM, Woodroofe MN, Cuzner ML. Characterization of microglia isolated from adult human and rat brain. J Neuroimmunol 1988; 19: 177 - 89.
11. Kondo Y, Takano F, Hojo H. Inhibitory effect of bisbenzylisoquinoline alkaloids on nitric oxide production in activated macrophages. Biochem Pharmacol 1993; 46: 1887 - 92.
12. Ohshima H, Oguchi S, Adachi H, Iida S, Suzuki H, Sugimura T, et al. Purification of nitric oxide synthase from bovine brain: Immunological characterization and tissue distribution. Biochem Biophys Res Commun 1992; 183: 238 - 44.
13. Kobuchi H, Droy-Lefaix MT, Christen Y, Packer L. Ginkgo biloba extract (EGb 761 ) : inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem Pharmacol 1997; 53: 897 - 903.
14. Maitra I, Marcocci L, Droy-Lefaix MT, Packer L. Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem Pharmacol 1995; 49: 1649 - 55.
15. Guinot W, Braquet P. Effects of the PAF antagonists, ginkgolides ( BN52063, BN52021), in various clinical indications. J Lipid Cell Signalling 1994; 10: 141 - 6.